During the past decade, A.S.L. Napoli 1 Ospedale San Giovanni Bosco conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "A.S.L. Napoli 1 Ospedale San Giovanni Bosco" #1 collaborator was "Study Alliance Leukemia (SAL) Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "A.S.L. Napoli 1 Ospedale San Giovanni Bosco" are "Leukemia" (2 trials). Many other conditions were trialed in "A.S.L. Napoli 1 Ospedale San Giovanni Bosco" in a lesser frequency.

Most popular intervention types in "A.S.L. Napoli 1 Ospedale San Giovanni Bosco" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "all-trans retinoic acid (ATRA)" (2 trials), "all-trans retinoic acid" (1 trials), "arsenic trioxide" (1 trials), "idarubicin" (1 trials) and "mercaptopurine" (1 trials). Other intervention names were less common.

The vast majority of trials in "A.S.L. Napoli 1 Ospedale San Giovanni Bosco" are 2 trials for "All" genders.

Currently, there are NaN active trials in "A.S.L. Napoli 1 Ospedale San Giovanni Bosco". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in A.S.L. Napoli 1 Ospedale San Giovanni Bosco, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in A.S.L. Napoli 1 Ospedale San Giovanni Bosco, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".